| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157492 | American Journal of Kidney Diseases | 2015 | 9 Pages |
Abstract
AKI in patients with HLH is frequent and adversely affects remission and survival. Early intensive management, including administration of etoposide, nephrotoxic drug withdrawal, prevention of tumor lysis syndrome, or aggressive supportive care, might improve kidney function and survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Florence MD, Nathanael MD, PhD, Emmanuel MD, Lionel MD, David MD, PhD, Marie-Noelle MD, PhD, Danielle MD, Remy MD, Benoit MD, PhD, Elie MD, PhD, Lara MD, PhD,